ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 756350 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 756350; 2) Community: the network communities that were significantly associated with the response to NSC 756350; 3) Molecule: the relationships between components within communities and NSC 756350; 4) MDR: the compounds that were significantly associated with the NSC 756350.

NSC Compound Enrichment Correlation
NSC 339137 PHYSALOLACTONE 0.0285477013888565 0.23087545
NSC 339579 7H-Pyrrolo[3,2-f]quinazoline-2,4-diamine, 7-[(3-nitrophenyl)methyl]-, monoacetate 0.0285477013888565 0.13319594
NSC 351521 Ethanesulfonic acid, 2-hydroxy-, compd. with 6-[(2,5-dimethoxyphenyl)methyl]-5-methylpyrido[2,3-d] pyrimidine-2,4-diamine (1:1) 0.0285477013888565 0.19442027
NSC 371777 Null 0.0285477013888565 0.18202269
NSC 603071 Aminocamptothecin 0.0285477013888565 0.024869056
NSC 660813 Null 0.0285477013888565 0.088605921
NSC 674268 Null 0.0285477013888565 0.051984934
NSC 681632 Camptothecin Derivative 0.0285477013888565 0.12495461
NSC 684043 1H-Imidazole-4-carboxamide, 5-[[(2-amino-2-carboxyethyl)thio]azo]- 0.0285477013888565 0.12112861
NSC 684118 Pyrido[3,4-g]quinoline-5,10-dione, 1,4-dihydro- 1-(dimethylamino)-4-methyl- 0.0285477013888565 0.32892325
Total:49  Current:29    [First] [Prev] [Next] [Last]